E-mail this page: News Release
Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex(R) Overactive Bladder Treatment for $400 Million in Cash
To (e-mail address):
Separate multiple addresses with commas. Maximum 200 characters.
Your e-mail address:
These e-mail addresses will be used to e-mail the page on your behalf and will not be used by Warner Chilcott for any marketing purposes.
Add a comment:
Link to page
Type in number:
This helps Warner Chilcott prevent automated submissions.